NCT04565405

Brief Summary

Biofilms pose a potential risk with reusable inner cannulas, by increasing the risk of infection. Effective decontamination is vital in eliminating these biofilms. An appropriate method of cleaning and decontamination to make inner cannula safe for reuse should be practiced. The current recommendations for cleaning inner cannula are varied with multiple techniques being put forth. The current practice of using sterile water to clean inner cannula is not supported by strong evidence. This Randomized Controlled Study looks into the microbiological efficacy of sterile water in cleaning inner cannulas.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Mar 2017

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 30, 2017

Completed
3.4 years until next milestone

First Submitted

Initial submission to the registry

September 8, 2020

Completed
17 days until next milestone

First Posted

Study publicly available on registry

September 25, 2020

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 16, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 16, 2020

Completed
Last Updated

September 25, 2020

Status Verified

September 1, 2020

Enrollment Period

3.6 years

First QC Date

September 8, 2020

Last Update Submit

September 21, 2020

Conditions

Keywords

TracheostomyInner cannulasDecontaminationMicrobiological evaluation

Outcome Measures

Primary Outcomes (1)

  • Efficacy of water vs detergent in cleaning tracheostomy inner cannulas

    Compare the colony forming units / ml before and after cleaning with water vs detergent

    1 week

Secondary Outcomes (2)

  • Economic evaluation

    2 years

  • Microbiological evaluation

    2 weeks

Study Arms (2)

AB (Detergent (A) followed by sterile water (B))

EXPERIMENTAL

Sequence: Detergent (A) followed by sterile water (B) The inner cannula will be cleaned with commercially available tracheostomy cleaning fluid / powder (Ex: Trachoe - Kapitex healthcare, UK) in the first visit, and then cleaned with sterile water in the second visit, at a minimum period of 24 hrs apart. Laboratory analysis of colony counts will be conducted on the saline flushing pre- and post-decontamination for each washing.

Other: DetergentOther: Sterile water

BA (Sterile water (B) followed by detergent (A))

EXPERIMENTAL

Sequence: Sterile water (B) followed by detergent (A) The inner cannula will be cleaned with sterile water in the first visit, and then cleaned with commercially available tracheostomy cleaning fluid / powder (Ex: Trachoe - Kapitex healthcare, UK) in the second visit, at a minimum period of 24 hrs apart. Laboratory analysis of colony counts will be conducted on the saline flushing pre- and post-decontamination for each washing.

Other: DetergentOther: Sterile water

Interventions

The tracheostomy inner cannulas will be washed with detergent.

AB (Detergent (A) followed by sterile water (B))BA (Sterile water (B) followed by detergent (A))

The tracheostomy inner cannulas will be washed with sterile water.

AB (Detergent (A) followed by sterile water (B))BA (Sterile water (B) followed by detergent (A))

Eligibility Criteria

Age21 Years - 100 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients aged between 21 - 100 years
  • Patients with a tracheostomy tube in situ

You may not qualify if:

  • Pregnant women
  • Prisoners
  • Patients with documented HIV, Hep C, Hep B
  • Patients with active tuberculosis
  • Patients being treated in Intensive Care Units
  • Patients with ongoing antibiotic treatment or within the last 24 hours
  • Unstable patients needing cardiorespiratory support

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Clinical Trials & Research Unit

Singapore, 529889, Singapore

RECRUITING

Related Publications (1)

  • Bjorling G, Belin AL, Hellstrom C, Schedin U, Ransjo U, Alenius M, Johansson UB. Tracheostomy inner cannula care: a randomized crossover study of two decontamination procedures. Am J Infect Control. 2007 Nov;35(9):600-5. doi: 10.1016/j.ajic.2006.11.006.

    PMID: 17980239BACKGROUND

MeSH Terms

Interventions

Detergents

Intervention Hierarchy (Ancestors)

Surface-Active AgentsSpecialty Uses of ChemicalsChemical Actions and UsesHousehold ProductsTechnology, Industry, and Agriculture

Study Officials

  • Hong Eng Chan

    Changi General Hospital

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Seok Hwee Koo, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Masking Details
Eligible patients will be randomized in 1:1 fashion using permuted blocks with different block sizes. The subjects and lab operators will be blinded to the block size and randomization. In the event unmasking need to be performed, a staff who is not involved in this study from Clinical Trial Unit will perform the unmasking.
Purpose
SUPPORTIVE CARE
Intervention Model
CROSSOVER
Model Details: This is a single centre, single blinded, randomized cross over study comparing two decontamination procedures Detergent (A) and Sterile water (B) on inner cannulas. To avoid the influence of confounding covariates, we propose to have a cross over study. The cross over patient will act as his own control. The selected patients will be randomly allocated to sequence AB or BA in 1:1 fashion using permuted blocks with different block sizes. The change of sequence A \> B and B \> A will take place only after minimum of 24 hours after the first part of sequence has been completed.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Senior Nurse Clinician

Study Record Dates

First Submitted

September 8, 2020

First Posted

September 25, 2020

Study Start

March 30, 2017

Primary Completion

November 16, 2020

Study Completion

November 16, 2020

Last Updated

September 25, 2020

Record last verified: 2020-09

Data Sharing

IPD Sharing
Will not share

Locations